CE2024-07-26T13:20:56
The single-dose gene therapy was approved for certain patients with haemophilia B in the US and Canada earlier this year, marketed as BEQVEZ.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-10T09:30:00Z
Sponsored by Capsugel
2026-06-29T06:00:00
Sponsored by Lubrizol Advanced Materials Europe BV
2026-04-30T10:37:00
Sponsored by Shimadzu
2026-03-27T15:37:00
Sponsored by IMA Pharma
2026-07-13T07:00:00
Sponsored by Thermo Fisher Scientific
2026-10-14T14:00:00
Sponsored by Particle Measuring Systems
2026-09-28T12:33:00
Sponsored by Gattefosse
Site powered by Webvision Cloud